|
ISIN No
|
INE044A01036
|
52Week High
|
967
|
Book Value (Rs.)
|
193.65
|
Face Value
|
1.00
|
|
Bookclosure
|
10/02/2022
|
52Week Low
|
653
|
EPS
|
12.10
|
P/E
|
75.66
|
|
Market Cap.
|
219695.11 Cr.
|
P/BV
|
4.73
|
Div Yield (%)
|
0.82
|
Market Lot
|
1.00
|
|
Security Type
|
Other
|
|
You can view the investment break up of the company with details such as Security name, Security type, Company type, investmement cost etc.
| YearEnd | Security Name | Security Type | Company Type | Cost of Investments |
| 2103 |
Sun Pharma Holdings
| Preference Share | Subsidiary | 7364.22 |
| 2103 |
Sun Pharma Holdings
| Equity Share | Subsidiary | 5403.15 |
| 2103 |
Sun Pharma (Netherlands) BV
| Equity Share | Subsidiary | 3987.73 |
| 2103 |
Zenotech Laboratories Ltd.
| Equity Share | Subsidiary | 158.07 |
| 2103 |
BNP Paribas Liquid Fund - Direct Plan - Growth
| Mutual Fund Scheme | Mutual Fund | 31.00 |
| 2103 |
Sun Pharmaceuticals Industries INC
| Equity Share | Subsidiary | 30.42 |
| 2103 |
Krebs Biochemicals & Industries Ltd.
| Equity Share | Company | 9.02 |
| 2103 |
Sun Pharmaceutical (Bangladesh) Ltd.
| Equity Share | Subsidiary | 6.81 |
|